Loading
The side-effects of cancer and its treatment that stop people eating: nausea, mouth soreness, taste changes, difficulty swallowing, early fullness, constipation, pain and low mood. Treating them is often the most effective nutrition intervention.
Nutrition impact symptoms explain much of the weight loss in head and neck, oesophageal, gastric and pancreatic cancer and during chemotherapy, and unlike cachexia they are reversible with targeted treatment (antiemetics, mouthcare, dysphagia diets, pancreatic enzyme replacement, laxatives, analgesia). Systematic screening with the PG-SGA symptom checklist or patient-reported outcome tools identifies them earlier than clinician assessment. Pancreatic exocrine insufficiency, present in most pancreatic cancer patients, is under-treated.
Showing the technology this term belongs to: Oncology nutrition assessment and medical nutrition therapy.
Shares Eating after a Whipple operation: slow stomach emptying, dumping and bowel changes, Weight loss, fat digestion and enzymes with gallbladder cancer, Pancreatic enzyme replacement therapy (PERT, pancreatin, Creon) for pancreatic exocrine insufficiency: why and how to take it, Enteral and parenteral nutrition support.
Shares Palliation in pancreatic cancer: biliary and duodenal stents, coeliac plexus block, enzymes and cachexia, Malnutrition screening tools (MUST, NRS-2002, MST, PG-SGA), Cancer cachexia, Pancreatic ductal adenocarcinoma.
Shares Pancreatic enzyme replacement therapy (PERT, pancreatin, Creon) for pancreatic exocrine insufficiency: why and how to take it, Malnutrition screening tools (MUST, NRS-2002, MST, PG-SGA), Oncology nutrition assessment and medical nutrition therapy, Cancer cachexia.
Shares Low-dose olanzapine for cancer anorexia (Tata Memorial), Cachexia, toxicity and the limits of the patient, Gastric & gastro-oesophageal junction cancer, Pancreatic ductal adenocarcinoma.
Shares Malnutrition screening tools (MUST, NRS-2002, MST, PG-SGA), Oncology nutrition assessment and medical nutrition therapy, Cancer cachexia, Gastric & gastro-oesophageal junction cancer.
Shares Cancer cachexia, Cachexia, toxicity and the limits of the patient, Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
Shares A dietitian in every gastrointestinal and head and neck tumour board, Malnutrition screening tools (MUST, NRS-2002, MST, PG-SGA), Oesophageal cancer, Gastric & gastro-oesophageal junction cancer.
Shares Oncology nutrition assessment and medical nutrition therapy, Cancer cachexia, Cachexia, toxicity and the limits of the patient, Pancreatic ductal adenocarcinoma.